Immune Thrombocytopenia Induced by Nivolumab in a Metastatic Non-Small Cell Lung Cancer Patient

Publisher： Karger

E-ISSN： 2296-5262|40|10|621-622

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.40, Iss.10, 2017-09, pp. : 621-622

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab

By  

Oncology, Vol. 93, Iss. 1, 2017-04 ,pp. : 62-66

Karger

Access to resources Recommend Favorite

Afatinib with Concurrent Radiotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 37, Iss. 5, 2014-04 ,pp. : 262-265

Karger

Access to resources Recommend Favorite

Fatal Thrombocytopenia and Thrombocytopathia: An Unusual Onset of Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 26, Iss. 3, 2003-07 ,pp. : 272-274

Karger

Access to resources Recommend Favorite

Restoration of Gefitinib Efficacy Following Chemotherapy in a Patient with Metastatic Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 33, Iss. 8-9, 2010-07 ,pp. : 466-469

Karger

Access to resources Recommend Favorite

Erlotinib Achieved Partial Response in a Non-Small Cell Lung Cancer Patient with Gefitinib-Induced Interstitial Lung Disease

By  

Case Reports in Oncology, Vol. 4, Iss. 3, 2011-09 ,pp. : 464-466

Karger

Access to resources Recommend Favorite